Javier Rodriguez Davita Inc. (DVA) insider trading activity

Javier Rodriguez is Chief Executive Officer of DAVITA INC.. Currently has a direct ownership of 875,258 shares of DVA, which is worth approximately $135 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 37,423 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 875K

4.47% 3M change

99.37% 12M change

Total Value Held $135 Million

Javier Rodriguez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	BUY Grant, award, or other acquisition	-	37,423 Added 4.1%	875,258 Common Stock
Sep 16 2024	SELL Open market or private sale	$8,252,500 $165.05 p/Share	50,000 Reduced 5.63%	837,835 Common Stock
Sep 13 2024	SELL Open market or private sale	$1,609,120 $162.85 p/Share	9,881 Reduced 1.1%	887,835 Common Stock
Aug 27 2024	SELL Open market or private sale	$1,238,551 $155.93 p/Share	7,943 Reduced 0.88%	897,716 Common Stock
Aug 26 2024	SELL Open market or private sale	$5,017,203 $155.93 p/Share	32,176 Reduced 3.43%	905,659 Common Stock
Aug 20 2024	SELL Sale (or disposition) back to the issuer	$50,850,040 $152.17 p/Share	334,166 Reduced 22.98%	1,119,763 Common Stock
Aug 20 2024	SELL Payment of exercise price or tax liability	$27,683,983 $152.17 p/Share	181,928 Reduced 16.25%	937,835 Common Stock
Aug 20 2024	BUY Exercise of conversion of derivative security	$50,850,000 $67.8 p/Share	750,000 Added 34.03%	1,453,929 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$21,935,158 $134.65 p/Share	162,905 Reduced 18.79%	703,929 Common Stock
Mar 06 2024	SELL Sale (or disposition) back to the issuer	$50,850,033 $134.65 p/Share	377,646 Reduced 30.35%	866,834 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	$50,850,000 $67.8 p/Share	750,000 Added 37.6%	1,244,480 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$1,308,155 $127.6 p/Share	10,252 Reduced 2.03%	494,480 Common Stock
Feb 28 2024	SELL Sale (or disposition) back to the issuer	$3,390,076 $127.6 p/Share	26,568 Reduced 5.0%	504,732 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	$3,390,000 $67.8 p/Share	50,000 Added 8.6%	531,300 Common Stock
Feb 27 2024	SELL Open market or private sale	$938,457 $126.87 p/Share	7,397 Reduced 1.51%	481,300 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$11,164,173 $125.26 p/Share	89,128 Reduced 13.81%	556,300 Common Stock
Feb 26 2024	SELL Sale (or disposition) back to the issuer	$30,510,079 $125.26 p/Share	243,574 Reduced 27.4%	645,428 Common Stock
Feb 26 2024	SELL Open market or private sale	$8,525,414 $126.11 p/Share	67,603 Reduced 12.15%	488,697 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	$30,510,000 $67.8 p/Share	450,000 Added 33.61%	889,002 Common Stock
Dec 14 2023	SELL Sale (or disposition) back to the issuer	$33,900,012 $108.8 p/Share	311,581 Reduced 37.39%	521,718 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$8,999,500 $108.8 p/Share	82,716 Reduced 15.85%	439,002 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$33,900,000 $67.8 p/Share	500,000 Added 37.5%	833,299 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$3,981,236 $96.86 p/Share	41,103 Reduced 10.98%	333,299 Common Stock
May 10 2023	SELL Sale (or disposition) back to the issuer	$5,847,702 $100.72 p/Share	58,059 Reduced 14.38%	345,776 Common Stock
May 10 2023	SELL Open market or private sale	$1,686,694 $99.71 p/Share	16,916 Reduced 5.09%	315,622 Common Stock

Also insider at

GILD

GILEAD SCIENCES, INC. Healthcare

Director